To examine the synthetic lethal effect of MDM2 inhibitor in vivo, we conducted tumor xenograft experiments in mice bearing HCT116 PTEN+/+and PTEN-/- CRC tumors. The gene discussed is MDM2; the disease is colorectal carcinoma.